I am an enthusiastic clinical researcher in Oral Medicine. Major areas of research interest for the past 8 years have been the effectiveness of new therapeutics for salivary glands dysfunction associated with rheumatic disease and cancer therapy and the use of modern non-invasive diagnostic techniques in the detection of early oral squamous cell carcinoma. Our Oral Medicine Research Group investigated the genetic predisposition to develop toxicity from anti-resorptive medications; we are currently investigating the potential of epigenetic therapy in high-risk oral epithelial dysplasia and the clinical and biological effects of the use of probiotic in patients with chronic immunologically-mediated oral diseases (oral lichen planus).